GGrantIndex
Sort

3,198 grants matching mrna vaccine

CNT-VECTORED DELIVERY OF MRNA FOR HIV-VACCINES

$299,999
Ferguson Tammy · Luna Innovations, Inc. · N01 · FY2017 · AI

Multiplexed CRISPR-based immune cell RNA profiling by flow and mass cytometry

$299,978
Mitchell O'Connell · Dahlia Biosciences, Inc. · R41 · FY2021 · AI

The mosquito salivary protein AgBR1 as vaccine candidate against Chikungunya

$299,969
Erol Fikrig · L2 Diagnostics, Llc · R41 · FY2025 · AI

The mosquito salivary protein AgBR1 as vaccine candidate against Chikungunya

$299,969
Erol Fikrig · L2 Diagnostics, Llc · R41 · FY2024 · AI

Development of a Pan-COVID-19 Vaccine Candidate

$299,967
Haitao Hu · Rna Therapeutics Inc. · R41 · FY2024 · AI

Layer-by-Layer Delivery of RNA-based HIV-1 Vaccines

$299,956
Ziyou Zhou · Luna Innovations, Inc. · N01 · FY2018 · AI

Chimeric Ligands for Induced Proximity (CLIP) platform for targeted proteome editing and upregulation of antigen presentation

$299,921
Luiz Miguel Quinn Camargo · Ubiquitx, Inc. · R41 · FY2024 · AI

Delivery of a candidate AgTRIOVx malaria vaccine by thermostable microneedle patches

$299,878
Karen G. Anthony · L2 Diagnostics, Llc · R41 · FY2024 · AI

Delivery of a candidate AgTRIOVx malaria vaccine by thermostable microneedle patches

$299,862
Karen G. Anthony · L2 Diagnostics, Llc · R41 · FY2025 · AI

Critical Fluid Nanosomes for Effective Targeted Delivery and Manufacture of siRNA-based Therapeutics

$299,591
Trevor Castor · Aphios Corporation · N43 · FY2017 · AI

Cost-Effective Manufacturing of Pharmaceutical mRNA

$299,559
Ambion Diagnostics, Inc. · R44 · FY2005 · GM

Early Life Vaccination to Prevent HIV acquisition during Adolescence

$299,339
Sallie R. Permar · Weill Medical Coll Of Cornell Univ · P01 · FY2021 · AI

A Multivalent mRNA Vaccine to Prevent Transmission of Tick-bornePathogens

$299,250
Sukanya Narasimhan · L2 Diagnostics, Llc · R41 · FY2025 · AI

A Self-Replicating RNA Vaccine Against HIV-1 Delivered Using A Nanoparticle Adjuvant

$299,184
Amit Khandhar · Pai Life Sciences, Inc. · N43 · FY2019 · AI

Harnessing mRNA Vaccine Technology for Precision Antimicrobial Delivery

$299,163
Ivan Liachko · Phase Genomics, Inc. · R43 · FY2025 · AI

mRNA Delivery of a Panel of Single-Domain Antibodies for Combinatorial Deciphering of Therapeutic Targets for Covid-19 Related Cytokine Release Syndrome

$299,128
Xiang Gao · Oncotrap, Inc. · R43 · FY2022 · AI

Targeted EGFR Antisense Gene Therapy for Brain Cancer

$299,059
Armagen Technologies, Inc. · R43 · FY2004 · CA

Improving gene expression via Massively Parallel Synonymous Codon Variant Screening

$298,634
Keith Wycoff · Planet Biotechnology, Inc. · R43 · FY2020 · GM

Regulation of B Lymphocyte Defects in Senescent Humans

$298,466
Bonnie B. Blomberg · University Of Miami School Of Medicine · R01 · FY2012 · AG

Regulation of B Lymphocyte Defects in Senescent Humans

$298,466
Bonnie B. Blomberg · University Of Miami School Of Medicine · R01 · FY2011 · AG

Expressing New Tumor Antigens by Inhibition of Nonsense Mediated mRNA Decay

$298,427
Eli Gilboa · University Of Miami School Of Medicine · R01 · FY2013 · CA

DIETARY DEFICIENCIES AND TUBERCULOSIS VACCINE EFFICIENCY

$298,368
Texas A&M University Health Science Ctr · R01 · FY2002 · AI

A Multivalent mRNA Vaccine to Prevent Transmission of Tick-bornePathogens

$298,362
Sukanya Narasimhan · L2 Diagnostics, Llc · R41 · FY2024 · AI

Integrative transcriptomics to uncover functional elements and disease-associated variants in RNA

$298,215
David Anthony Hendrix · Oregon State University · R01 · FY2022 · GM

Development of a Next-Generation Nucleic Acid Force Field

$298,071
Jay W. Ponder · Washington University · R01 · FY2024 · GM